Skip to menu Skip to content Skip to footer

Targeting chronic NLRP3 mediated neuroinflammation in Parkinson?s disease using clinically validated kinase inhibitor drugs (2017-2018)

Experts

Dr Richard Gordon

Honorary Associate Professor
UQ Centre for Clinical Research
Faculty of Health, Medicine and Behavioural Sciences
Richard Gordon
Richard Gordon